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A commentary on
Circular RNAs are the predominant tran-
script isoform from hundreds of human
genes in diverse cell types
by Salzman, J., Gawad, C., Wang,
P. L., Lacayo, N., and Brown, P. O.
(2012). PLoS ONE 7:e30733. doi:
10.1371/journal.pone.0030733
Natural RNA circles function as efficient
microRNA sponges
by Hansen, T. B., Jensen, T. I., Clausen,
B. H., Bramsen, J. B., Finsen, B.,
Damgaard, C. K., et al. (2013). Nature
495, 384–388. doi: 10.1038/nature11993
Circular RNAs are a large class of animal
RNAs with regulatory potency
by Memczak, S., Jens, M., Elefsinioti,
A., Torti, F., Krueger, J., Rybak, A.,
et al. (2013). Nature 495, 333–338. doi:
10.1038/nature11928
Circular RNAs (circRNAs) are a nat-
urally occurring family of noncoding
RNAs (ncRNAs) highly represented in
the eukaryotic transcriptome. Recently
characterized, traditional methods of
RNA detection and analysis requiring
a free 5′ or 3′ ribonucleotide terminus
may have significantly underestimated
circRNA abundance and significance in
eukaryotic cells (Salzman et al., 2012;
Wilusz and Sharp, 2013; unpublished
observations). Intrinsically resistant to
exonucleolytic RNA decay, circRNAs
appear to be enriched inmammalian brain
tissues (Hansen et al., 2013; Memczak
et al., 2013). Interestingly, specific ncR-
NAs such as the evolutionary ancient
microRNA-7 (miRNA-7; chr 9q21.32;
an important post-transcriptional regu-
lator of human brain gene expression),
are not only highly abundant in human
brain, but are also associated with a
circRNA for miRNA-7 (ciRS-7), in the
same tissues; ciRS-7 contains multi-
ple, tandem anti-miRNA-7 sequences
(Burmistrova et al., 2007; Hansen et al.,
2013; Lukiw et al., 2013). ciRS-7 thereby
acts as a kind of endogenous, competing,
anti-complementary miRNA “sponge”
to adsorb, and hence quench, normal
miRNA-7 functions. Using Northern
blot hybridization techniques and the
circularity-sensitive circRNA probe
RNaseR we here provide initial evidence
of a mis-regulated miRNA-7-circRNA sys-
tem in the sporadic Alzheimer’s disease
(AD) hippocampal CA1 region (Figure 1).
Deficits in ciRS-7, and ciRS-7 “sponging
activities” might be expected to increase
ambient miRNA-7 levels in AD-affected
brain cells, as is observed, to ultimately
FIGURE 1 | (A) Detection of circRNA for miRNA-7 (ciRS-7) in sporadic Alzheimer’s disease (AD) and
age-matched control hippocampal CA1 [control (C) N = 4; AD (A) N = 6]; the single upper ciRS-7
(∼1400 nt) band contains ∼70 selectively conserved miRNA-7 binding sites as previously described
(Hansen et al., 2013); a lower 28S RNA served as an internal loading control; all samples depleted
of rRNA were treated with 50 units of RNaseR prior to electrophoresis RNaseR is a processive,
Mg++-dependent hydrolytic exoribonuclease that degrades linear but not circular RNA; see
Hansen et al. (2013); predicted circular transcripts consistently resisted an RNaseR challenge; 30 ug
total AD and control hippocampal CA1 RNA was separated on agarose gels, transferred and probed
with biotinylated or radiolabeled miRNA-7 probes as previously described (Colangelo et al., 2002;
Hansen et al., 2013); detection was performed using a nonisotopic BrightStar BioDetect Kit
(Ambion, Austin, TX; detection limit ∼100 fg) or by standard autoradiography (Lukiw et al., 1992);
(B) AD ciRS-7 is significantly reduced to about 0.18-fold of control (con) in a study of 20 control and
AD (AD) hippocampal CA1 samples; this implicates loss of miRNA-7 sponge effects, an ambient
up-regulation of miRNA-7 (as is observed), and down-regulation of a family of miRNA-7-sensitive
mRNAs in the sporadic AD brain; other circRNAs may be involved; there were no significant
differences between age for control or AD tissues [mean ± 1 standard deviation (SD) = 75.4 ± 8.3
year vs. 77.5 ± 7.6 year]; all AD cases were for moderate-to-advanced stages of AD; all
post-mortem intervals were 2.1 h or less (Colangelo et al., 2002); there were no significant
differences in age, ApoE allele status, RNA quality (all RIN values were 8.1–9.0) or yield between
the control or AD groups (p > 0.05, ANOVA); a dashed horizontal line at 1.0 indicates homeostatic
(control) ciRS-7 levels for ease of comparison; ∗p < 0.001 (ANOVA).
contribute to the down-regulation of
selective miRNA-7-sensitive messenger
RNA (mRNA) targets (Cogswell et al.,
2008; unpublished observations). The
presence of up-regulated miRNA-7, due to
a deficiency in ciRS-7 “sponging” effects,
has high probability to down-regulate AD-
relevant targets, such as, for example,
the ubiquitin protein ligase A (UBE2A;
miRNA-7-UBE2A mRNA energy of asso-
ciation, EA = −22.86 kcal/mol). UBE2A,
an autophagic, phagocytic protein essen-
tial in the clearance of amyloid peptides
in AD and other progressive inflamma-
tory degenerations of the human CNS, is
depleted in AD brain (Bingol and Sheng,
2011; Lonskaya et al., 2013). Such miRNA-
mRNA regulatory systems mediated by a
family of cell- and/or tissue-enriched cir-
cRNAs may represent another important
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layer of epigenetic control over gene
expression in health and disease. Indeed,
technological advancement and recent dis-
coveries in the field of ncRNAs continue
to challenge our basic doctrines of nucleic
acid biochemistry and evolutionary biol-
ogy. Deficits in other circRNA-mediated
“miRNA sponging systems” and ambi-
ent up-regulation of specific inducible
miRNAs may help explain the widely
observed, generalized and progressive
down-regulation of gene expression that
is characteristic of the sporadic AD brain
(Loring et al., 2001; Colangelo et al., 2002;
Ginsberg et al., 2012; Lukiw, 2013).
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